Opinion

Video

Treatment Sequencing With Androgen Receptor-Targeted Therapies for mCRPC

Key opinion leaders discuss considerations for sequencing androgen receptor-targeted therapies in metastatic castration-resistant prostate cancer, evaluating their benefits in first-line versus second-line treatment settings.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
1 expert in this video
1 expert in this video
© 2025 MJH Life Sciences

All rights reserved.